New Product Newswire
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
FDA Approves Remibrutinib for Adults With Chronic Spontaneous Urticaria
Episode 8: Stay in Sync with Innovations in Medication Decision Support
FDA Approves Bumetanide Nasal Spray for Edema Associated With Heart Failure, Liver Disease
FDA Approves Ruxolitinib Cream for Atopic Dermatitis in Children 2 Years and Older
FDA Approves Denosumab-Kyqq as Biosimilar for Prolia, Xgeva
FDA Approves Medtronic’s MiniMed System for Type 2 Diabetes